Affinity Investment Advisors, LLC Charles River Laboratories International, Inc. Transaction History

Affinity Investment Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 09, 2018	SELL	$112.11 - $134.54 $2.05 Million - $2.46 Million	-18,250 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$102.37 - $117.25 $4,094 - $4,690	40 Added 0.22%	18,250 $2.05 Million
Q3 2017 Oct 31, 2017	BUY	$96.72 - $109.26 $1.76 Million - $1.99 Million	18,210	18,210 $1.97 Million

691

51.6M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.38B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Affinity Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Affinity Investment Advisors, LLC with notifications on news.